期刊:Zeitschrift Fur Gastroenterologie [Thieme Medical Publishers (Germany)] 日期:2011-05-01卷期号:49 (05)被引量:4
标识
DOI:10.1055/s-0031-1279854
摘要
Purpose: We aimed to identify prognostic factors for patients with hepatocellular carcinoma (HCC) treated with sorafenib and to evaluate the efficacy of sorafenib with respect to liver function.